相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914
Gunther Kern et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
Eduardo Asin-Prieto et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2015)
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases
Gregory S. Basarab et al.
SCIENTIFIC REPORTS (2015)
In Vitro Antibacterial Activity of AZD0914, a New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-Positive, Fastidious Gram-Negative, and Atypical Bacteria
Michael D. Huband et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Characterization of the Novel DNA Gyrase Inhibitor AZD0914: Low Resistance Potential and Lack of Cross-Resistance in Neisseria gonorrhoeae
Richard A. Alm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea
Susanne Jacobsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae
Daniel Golparian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism
Claudine Mayer et al.
CHEMICAL REVIEWS (2014)
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
Magnus Unemo et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014
D. Golparian et al.
EUROSURVEILLANCE (2014)
Advanced Heat Map and Clustering Analysis Using Heatmap3
Shilin Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia
Marcus Y. Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia
Phillip J. Read et al.
SEXUAL HEALTH (2013)
High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure
Magnus Unemo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment
Catherine A. Ison
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea
Magnus Unemo et al.
FUTURE MICROBIOLOGY (2012)
Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain
Jordi Camara et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
Makoto Ohnishi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
Joseph Meletiadis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
Stephanie A. Chisholm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes
Magnus Unemo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
A fully defined, clear and protein-free liquid medium permitting dense growth of Neisseria gonorrhoeae from very low inocula
Jeremy James Wade et al.
FEMS MICROBIOLOGY LETTERS (2007)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens
RR Regoes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli
CY Chen et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2003)
Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters
MR Jacobs
CLINICAL MICROBIOLOGY AND INFECTION (2001)
分享论文
